How the service process works

Our CRO services entail a streamlined workflow that begins with you selecting the PDO models you are interested in and indicating the analysis you require. We will then design a scope of work, carry out the experiment, and furnish you with a report that is custom-tailored to address your specific research question.

PDO Screen

Patient-derived organoid screening platform

PDO Screen is built upon the recent success of our organoid screening platform which led to the first oncology agent to be approved for clinical trials within 5 years of development.

Select from an extensive panel of well-characterized patient-derived organoid models from multiple epithelial tissue types, disease indications, and mutational signatures to evaluate the efficacy and prioritize your lead candidate with confidence.

enroll now

Custom Services

Can’t find what you are looking for? Leverage our state-of-the-art technology to develop new models that meet your specific needs.

discover more

Want to know more?


First clinical candidate developed using HUB Organoids makes it to the clinical trials within five years

read more


Accelerating oncology drug discovery using HUB Organoids

download now


Patient-derived organoids predict clinical response: a patient in the lab

download now

Get in touch

Discover the transformative potential of our technology with a free consultation with an expert

Have any questions?

contact us